Ignite Creation Date:
2024-05-06 @ 8:04 PM
Last Modification Date:
2024-10-26 @ 3:19 PM
Study NCT ID:
NCT06232564
Status:
RECRUITING
Last Update Posted:
2024-01-30
First Post:
2023-12-14
Brief Title:
A Study of Etoposide-carboplatin in Combination With Pembrolizumab and Lenvatinib Maintenance in HG-NETs
Sponsor:
Imperial College London
Organization:
Imperial College London
Organization Data
Organization:
Imperial College London
Class:
OTHER
Study ID:
1004397
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Imperial College London
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None